The conference is to take place at Stalheim hotel, beautifully located at the West coast of Norway, 19th to 23rd May 2007.
It is still possible to register!
PhD students get a 50 % discount.
Dysregulation of signalling pathways downstream of receptor tyrosine kinases (RTKs) is a frequent event in carcinogenesis. This meeting, the first in a series sponsored by the "Norsk Hydro's Fund" for cancer research, will discuss key concepts of RTK signalling pathways, and how such signalling is modulated by intracellular trafficking. Examples of how proper receptor trafficking has a tumour suppressor function will be provided, and the mechanisms of intracellular trafficking of RTKs and other receptors will be explored. Finally, novel anti-cancer drugs that target RTKs and their pathways will be highlighted.
Invited lectures will be given by scientists who are world leaders within RTK signalling and membrane trafficking, and a few short talks will be chosen from submitted abstracts. There will also be poster sessions covering the main topics of the meeting.
Arranged by: Sjur Olsnes, Kirsten Sandvig, Harald Stenmark, Tore Geir Iversen, Tor Erik Rusten, Jørgen Wesche
The organizing committee would be grateful if you could forward the following meeting invitation to others who might be interested.
Please visit the website for more information: https://www.ous-research.no/stalheim2007/
The Norwegian Institute for Cancer Research
Department for Biochemistry